. home.aspx

home.aspx
   

Hepatitis C: commitment to a cure

July 28, 2016 / NIAMH LOUISE MARRIOTT

In previous years, the diagnosis would be a death sentence – Hepatitis C. However, new treatments are constantly being discovered and with a wealth of antiviral medication available on the market, is a cure just around the corner. Ealier this week, AbbVie announced that the Food and Drug Administration (FDA) has approved their Hep C drug, Viekira XR (dasabuvir, ombitasvir, paritaprevir and ritonavir), for the treatment of patients with chronic genotype 1 (GT1) hepatitis.